Gilead in talks to expand global supply of COVID-19 drug remdesivir

Gilead Sciences Inc said on Tuesday it was in discussions with chemical and drug manufacturers to produce its experimental COVID-19 drug remdesivir for Europe, Asia and the developing world through at least 2022.

from Moneycontrol Latest News https://ift.tt/2yxWJDh